PRODUCT | CATHEGORY | STATUS |
---|---|---|
ABAMETAPIR | Head Lice Infestation | Ready for validation |
ALECTINIB | Lung cancer | Early development |
ATROPINE | Eye surgery | Commercial – DMF |
AXITINIB | Breast cancer | Early development |
BEMPEDOIC ACID | Hypercholesterolemia | Under development |
CLASCOTERONE | Acne | Ready for validation |
CYSTEAMINE BITARTRATE | Cystinosis | Commercial – DMF |
CYSTEAMINE HCL | Cystinosis | Ready for validation |
ETRASIMOD | Ulcerative colitis | Under evaluation |
OZANIMOD | Multiple sclerosis | Ready for validation |
PONESIMOD | Multiple sclerosis | Under development |
RIBOCICLIB | Breast cancer | Under development |
RUCAPARIB | Ovarian cancer | Early development |
RUXOLITINIB | Myelofibrosis | Ready for validation |
SELEGILINE | Parkinson’s disease | Under development |
TIPIRACIL | Colorectal cancer | Ready for validation |
VORTIOXETINE | Major depressive disorder | Ready for validation |
Development, manufacturing, marketing of the above products is performed in countries where such activities are not in conflict with the existing patents. |